Design, synthesis and exploration of novel triazinoindoles as potent quorum-sensing inhibitors and radical quenchers.

IF 3.2 4区 医学 Q3 CHEMISTRY, MEDICINAL Future medicinal chemistry Pub Date : 2024-03-01 Epub Date: 2024-02-20 DOI:10.4155/fmc-2023-0313
Jyoti Rasgania, Renu Gavadia, Neetu Sahu, Pinki Sharma, Nar S Chauhan, Vicky Saharan, Rajeev K Kapoor, Komal Jakhar
{"title":"Design, synthesis and exploration of novel triazinoindoles as potent quorum-sensing inhibitors and radical quenchers.","authors":"Jyoti Rasgania, Renu Gavadia, Neetu Sahu, Pinki Sharma, Nar S Chauhan, Vicky Saharan, Rajeev K Kapoor, Komal Jakhar","doi":"10.4155/fmc-2023-0313","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Antimicrobial resistance has become a critical health concern, and quorum-sensing exacerbates the resistance by facilitating cell-to-cell communication within the microbial community, leading to severe pathogenic outbreaks. <b>Methods & results:</b> Novel 1-(2-((5<i>H</i>-[1,2,4]-triazino[5,6-<i>b</i>]indol-3-yl)thio)acetyl)indoline-2,3-diones were synthesized. The title compounds exhibit outstanding anti-quorum-sensing efficacy, and compound <b>7g</b> demonstrated the maximum proficiency (IC<sub>50</sub> = 0.0504 μg/ml). The hybrids displayed potent antioxidant action, and compound <b>7c</b> showed the highest antioxidant ability (IC<sub>50</sub> = 40.71 μg/ml). Molecular docking of the isatin hybrids against DNA gyrase and quorum-sensing receptor CviR validated the observed <i>in vitro</i> findings. The befitting pharmacokinetic profile of the synthesized drug candidates was ascertained through absorption, distribution, metabolism, excretion and toxicity screening. <b>Conclusion:</b> The remarkable biocompetence of the synthesized triazinoindoles may help to combat drug-resistant infections.</p>","PeriodicalId":12475,"journal":{"name":"Future medicinal chemistry","volume":" ","pages":"399-416"},"PeriodicalIF":3.2000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future medicinal chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4155/fmc-2023-0313","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/20 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Antimicrobial resistance has become a critical health concern, and quorum-sensing exacerbates the resistance by facilitating cell-to-cell communication within the microbial community, leading to severe pathogenic outbreaks. Methods & results: Novel 1-(2-((5H-[1,2,4]-triazino[5,6-b]indol-3-yl)thio)acetyl)indoline-2,3-diones were synthesized. The title compounds exhibit outstanding anti-quorum-sensing efficacy, and compound 7g demonstrated the maximum proficiency (IC50 = 0.0504 μg/ml). The hybrids displayed potent antioxidant action, and compound 7c showed the highest antioxidant ability (IC50 = 40.71 μg/ml). Molecular docking of the isatin hybrids against DNA gyrase and quorum-sensing receptor CviR validated the observed in vitro findings. The befitting pharmacokinetic profile of the synthesized drug candidates was ascertained through absorption, distribution, metabolism, excretion and toxicity screening. Conclusion: The remarkable biocompetence of the synthesized triazinoindoles may help to combat drug-resistant infections.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
设计、合成和探索新型三嗪吲哚作为有效的定量感应抑制剂和自由基淬灭剂。
背景:抗菌药耐药性已成为一个严重的健康问题,而法定人数感应通过促进微生物群落内细胞间的交流加剧了耐药性,导致严重的病原体爆发。方法与结果:合成了新型 1-(2-((5H-[1,2,4]-三嗪并[5,6-b]吲哚-3-基)硫)乙酰基)吲哚啉-2,3-二酮。标题化合物具有出色的抗定量感应功效,其中化合物 7g 的功效最高(IC50 = 0.0504 μg/ml)。杂交化合物具有很强的抗氧化作用,其中化合物 7c 的抗氧化能力最强(IC50 = 40.71 μg/ml)。isatin杂交化合物与DNA回旋酶和定量感应受体CviR的分子对接验证了体外观察到的结果。通过吸收、分布、代谢、排泄和毒性筛选,确定了合成候选药物的药代动力学特征。结论合成的三嗪吲哚具有卓越的生物能力,可能有助于抗击耐药性感染。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Future medicinal chemistry
Future medicinal chemistry CHEMISTRY, MEDICINAL-
CiteScore
5.80
自引率
2.40%
发文量
118
审稿时长
4-8 weeks
期刊介绍: Future Medicinal Chemistry offers a forum for the rapid publication of original research and critical reviews of the latest milestones in the field. Strong emphasis is placed on ensuring that the journal stimulates awareness of issues that are anticipated to play an increasingly central role in influencing the future direction of pharmaceutical chemistry. Where relevant, contributions are also actively encouraged on areas as diverse as biotechnology, enzymology, green chemistry, genomics, immunology, materials science, neglected diseases and orphan drugs, pharmacogenomics, proteomics and toxicology.
期刊最新文献
A comprehensive insight into naphthalimides as novel structural skeleton of multitargeting promising antibiotics. A call to develop tramadol enantiomer for overcoming the tramadol crisis by reducing addiction. Advancements in PROTAC-based therapies for neurodegenerative diseases. EGFR molecular degraders: preclinical successes and the road ahead. How does machine learning augment alchemical binding free energy calculations?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1